Fonazine

• CAT Number: I006829
• CAS Number: 7456-24-8
• Molecular Formula: C19H25N3O2S2
• Molecular Weight: 391.55
• Purity: ≥95%
• Synonyms: Fonazine; Dimetotiazine; Dimethothiazine; Dimetiotazine; Banistyl; Dimethodin; fonazine mesylate; fonazine monomesylate ;Migristene; Promaquid.;10-(2-(Dimethylamino)propyl)-N,N-dimethylphenothiazine-2-sulfonamide
• Target: Neuronal Signaling
• Solubility: Soluble in DMSO, not in water
• Storage: 0 - 4°C for short term or -20 °C for long term
• IUPAC Name: 10-[2-(dimethylamino)propyl]-N,N-dimethylphenothiazine-2-sulfonamide
• InChI: InChI=1S/C19H25N3O2S2/c1-14(20(2)3)13-22-16-8-6-7-9-18(16)25-19-11-10-15(12-17(19)22)26(23,24)21(4)5/h6-12,14H,13H2,1-5H3
• InChIKey: VWNWVCJGUMZDIU-UHFFFAOYSA-N
• SMILES: CC(CN1C2=CC=CC=C2SC3=C1C=C(C=C3)S(=O)(=O)N(C)C)N(C)C

Fonazine（Cat No.:I006829）is an experimental small molecule compound with potential applications in the treatment of cancer and other diseases. It functions by targeting specific enzymes or signaling pathways involved in tumor cell growth, survival, and metastasis. Fonazine has been studied for its ability to disrupt the molecular mechanisms that cancer cells rely on to proliferate and evade treatment. Although it has shown promise in preclinical studies, further research and clinical trials are necessary to determine its safety, efficacy, and therapeutic potential in human patients, particularly in oncology.